-
1
-
-
0026325650
-
Clinical use of botulinum toxin
-
National Institutes of Health Consensus Development Conference Statement, November 12-14, 1990
-
Clinical use of botulinum toxin. National Institutes of Health Consensus Development Conference Statement, November 12-14, 1990. Arch Neurol 1991;48:1294-8.
-
(1991)
Arch Neurol
, vol.48
, pp. 1294-1298
-
-
-
2
-
-
0025160754
-
Assessment: The clinical usefulness of botulinum toxin-A in treating neurologic disorders
-
Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
-
Assessment: the clinical usefulness of botulinum toxin-A in treating neurologic disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1990;40:1332-6.
-
(1990)
Neurology
, vol.40
, pp. 1332-1336
-
-
-
3
-
-
0024729961
-
Botulinum toxin therapy of eye muscle disorders. Safety and effectiveness
-
American Academy of Ophthalmology
-
Botulinum toxin therapy of eye muscle disorders. Safety and effectiveness. American Academy of Ophthalmology. Ophthalmology 1989;96 (Suppl):37-41.
-
(1989)
Ophthalmology
, vol.96
, Issue.SUPPL.
, pp. 37-41
-
-
-
4
-
-
0036840022
-
Therapeutic use of botulinum toxins: Background and history
-
Setler PE. Therapeutic use of botulinum toxins: background and history. Clin J Pain 2002;18 (6 Suppl):S119-24.
-
(2002)
Clin J Pain
, vol.18
, Issue.6 SUPPL.
-
-
Setler, P.E.1
-
6
-
-
0030639556
-
Cosmetic uses of botulinum A exotoxin
-
Carruthers A, Carruthers J. Cosmetic uses of botulinum A exotoxin. Adv Dermatol 1997;12:325-47.
-
(1997)
Adv Dermatol
, vol.12
, pp. 325-347
-
-
Carruthers, A.1
Carruthers, J.2
-
7
-
-
0031751613
-
Clinical indications and injection technique for the cosmetic use of botulinum A exotoxin
-
Carruthers A, Carruthers J. Clinical indications and injection technique for the cosmetic use of botulinum A exotoxin. Dermatol Surg 1998;24:1189-94.
-
(1998)
Dermatol Surg
, vol.24
, pp. 1189-1194
-
-
Carruthers, A.1
Carruthers, J.2
-
8
-
-
0036718418
-
Anesthesia with EMLA cream for botulinum A toxin injection into eyelids
-
Soylev MF, Kocak N, Kuvaki B, et al. Anesthesia with EMLA cream for botulinum A toxin injection into eyelids. Ophthalmologica 2002;216:355-8.
-
(2002)
Ophthalmologica
, vol.216
, pp. 355-358
-
-
Soylev, M.F.1
Kocak, N.2
Kuvaki, B.3
-
9
-
-
7044231245
-
Lidocaine tape (Penles) reduces the pain of botulinum toxin injection for Meige syndrome
-
Onguchi T, Takano Y, Dogru M, et al. Lidocaine tape (Penles) reduces the pain of botulinum toxin injection for Meige syndrome. Am J Ophthalmol 2004;138:654-5.
-
(2004)
Am J Ophthalmol
, vol.138
, pp. 654-655
-
-
Onguchi, T.1
Takano, Y.2
Dogru, M.3
-
11
-
-
0041379687
-
Beneficial use of an ice-balloon as part of botulinum toxin type A therapy for facial dynamic wrinkles and other skin injection procedures
-
Cerqueiro J, Matti B. Beneficial use of an ice-balloon as part of botulinum toxin type A therapy for facial dynamic wrinkles and other skin injection procedures. Br J Plast Surg 2003;56:619.
-
(2003)
Br J Plast Surg
, vol.56
, pp. 619
-
-
Cerqueiro, J.1
Matti, B.2
-
12
-
-
0035025164
-
Emla versus ice as a topical anesthetic
-
Kuwahara RT, Skinner RB. Emla versus ice as a topical anesthetic. Dermatol Surg 2001;27:495-6.
-
(2001)
Dermatol Surg
, vol.27
, pp. 495-496
-
-
Kuwahara, R.T.1
Skinner, R.B.2
-
13
-
-
9444291301
-
Evaluating the effects of ice application on the pain felt during botulinum toxin type-A injections: A prospective, randomized, single-blind controlled trial
-
Sarifakioglu N, Sarifakioglu E. Evaluating the effects of ice application on the pain felt during botulinum toxin type-A injections: a prospective, randomized, single-blind controlled trial. Ann Plast Surg 2004;53:543-6.
-
(2004)
Ann Plast Surg
, vol.53
, pp. 543-546
-
-
Sarifakioglu, N.1
Sarifakioglu, E.2
-
14
-
-
0022004085
-
Botulinum toxin A injection as a treatment for blepharospasm
-
Scott A, Kenny EG, Stubbs HA. Botulinum toxin A injection as a treatment for blepharospasm. Arch Ophthalmol 1985;103:347-50.
-
(1985)
Arch Ophthalmol
, vol.103
, pp. 347-350
-
-
Scott, A.1
Kenny, E.G.2
Stubbs, H.A.3
-
15
-
-
0021145568
-
Treatment of blepharospasm with botulinum toxin: A preliminary report
-
Frueh BR, Felt DP, Wojno TH, Musch DC. Treatment of blepharospasm with botulinum toxin: a preliminary report. Arch Ophthalmol 1984;102:1464-8.
-
(1984)
Arch Ophthalmol
, vol.102
, pp. 1464-1468
-
-
Frueh, B.R.1
Felt, D.P.2
Wojno, T.H.3
Musch, D.C.4
-
16
-
-
0030950709
-
Blepharospasm and hemifacial spasm: Randomized trial to determine the most appropriate location for botulinum toxin injections
-
Price J, Farish S, Taylor H, O'Day J. Blepharospasm and hemifacial spasm: randomized trial to determine the most appropriate location for botulinum toxin injections. Ophthalmology 1997;104:865-8.
-
(1997)
Ophthalmology
, vol.104
, pp. 865-868
-
-
Price, J.1
Farish, S.2
Taylor, H.3
O'Day, J.4
-
18
-
-
0023147760
-
Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age-related lower eyelid entropion
-
Carruthers JDA, Stubbs HA. Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age-related lower eyelid entropion. Can J Neurol Sci 1987;14:42-5.
-
(1987)
Can J Neurol Sci
, vol.14
, pp. 42-45
-
-
Carruthers, J.D.A.1
Stubbs, H.A.2
-
19
-
-
0021369330
-
Blepharospasm: Demographic and clinical survey of 250 patients
-
Jankovic J, Orman J. Blepharospasm: demographic and clinical survey of 250 patients. Ann Ophthalmol 1984;16:371-6.
-
(1984)
Ann Ophthalmol
, vol.16
, pp. 371-376
-
-
Jankovic, J.1
Orman, J.2
-
20
-
-
0023691092
-
Long-term results and complications of botulinum A toxin in the treatment of blepharospasm
-
Dutton J, Buckley EG. Long-term results and complications of botulinum A toxin in the treatment of blepharospasm. Ophthalmology 1988;95:1529-34.
-
(1988)
Ophthalmology
, vol.95
, pp. 1529-1534
-
-
Dutton, J.1
Buckley, E.G.2
-
22
-
-
0028016230
-
Botulinum toxin A for hyperkinetic facial lines: Results of a double-blind, placebo-controlled study
-
Keen M, Blitzer A, Aviv J, et al. Botulinum toxin A for hyperkinetic facial lines: results of a double-blind, placebo-controlled study. Plast Reconstr Surg 1994;94:94-9.
-
(1994)
Plast Reconstr Surg
, vol.94
, pp. 94-99
-
-
Keen, M.1
Blitzer, A.2
Aviv, J.3
-
23
-
-
0031782355
-
Cosmetic use of botulinum A exotoxin for the aging neck
-
Brandt FS, Bellman B. Cosmetic use of botulinum A exotoxin for the aging neck. Dermatol Surg 1998;24:1232-4.
-
(1998)
Dermatol Surg
, vol.24
, pp. 1232-1234
-
-
Brandt, F.S.1
Bellman, B.2
-
24
-
-
0036219395
-
Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative: A double-blind, randomized controlled trial
-
Alam M, Dover JS, Arndt KA. Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative: a double-blind, randomized controlled trial. Arch Dermatol 2002;138:510-4.
-
(2002)
Arch Dermatol
, vol.138
, pp. 510-514
-
-
Alam, M.1
Dover, J.S.2
Arndt, K.A.3
-
25
-
-
0036622034
-
Surgical pearl: The use of the Ultra-Fine II short needle 0.3-cc insulin syringe for botulinum toxin injections
-
Flynn TC, Carruthers A, Carruthers J. Surgical pearl: The use of the Ultra-Fine II short needle 0.3-cc insulin syringe for botulinum toxin injections. J Am Acad Dermatol 2002;46:931-3.
-
(2002)
J Am Acad Dermatol
, vol.46
, pp. 931-933
-
-
Flynn, T.C.1
Carruthers, A.2
Carruthers, J.3
-
26
-
-
0038793676
-
Reduction in injection pain with botulinum toxin type B further diluted using saline with preservative: A double-blind, randomized controlled trial
-
van Laborde S, Dover JS, Moore M, et al. Reduction in injection pain with botulinum toxin type B further diluted using saline with preservative: a double-blind, randomized controlled trial. J Am Acad Dermatol 2003;48:875-7.
-
(2003)
J Am Acad Dermatol
, vol.48
, pp. 875-877
-
-
Van Laborde, S.1
Dover, J.S.2
Moore, M.3
-
27
-
-
7044227820
-
Consensus recommendations on the use of botulinum toxin type a in facial aesthetics
-
Botox Consensus Group
-
Carruthers J, Fagien S, Matarasso SL, Botox Consensus Group. Consensus recommendations on the use of botulinum toxin type a in facial aesthetics. Plast Reconstr Surg 2004;114 (6 Suppl):1S-22S.
-
(2004)
Plast Reconstr Surg
, vol.114
, Issue.6 SUPPL.
-
-
Carruthers, J.1
Fagien, S.2
Matarasso, S.L.3
-
28
-
-
0001869716
-
Botulinum neurotoxin: Origin, structure, molecular actins, and antibody
-
Moore AP, ed. Oxford: Blackwell Science
-
Hambleton P, Moore AP. Botulinum neurotoxin: origin, structure, molecular actins, and antibody. In: Moore AP, ed. Handbook of botulinum toxin treatment. Oxford: Blackwell Science, 1995:1-27.
-
(1995)
Handbook of Botulinum Toxin Treatment
, pp. 1-27
-
-
Hambleton, P.1
Moore, A.P.2
-
29
-
-
33748271738
-
Botulinum toxin: Chemistry, pharmacology, toxicity, and immunology
-
Brin MF. Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle Nerve Suppl. 1997;20:S146-68.
-
(1997)
Muscle Nerve Suppl
, vol.20
-
-
Brin, M.F.1
-
30
-
-
27744456489
-
Visualization of binding and transcytosis of botulinum toxin by human intestinal epithelial cells
-
Ahsan CR, Hajnoczky G, Maksymowych AB, Simpson LL. Visualization of binding and transcytosis of botulinum toxin by human intestinal epithelial cells. J Pharmacol Exp Ther 2005;315:1028-35.
-
(2005)
J Pharmacol Exp Ther
, vol.315
, pp. 1028-1035
-
-
Ahsan, C.R.1
Hajnoczky, G.2
Maksymowych, A.B.3
Simpson, L.L.4
-
31
-
-
0022556314
-
125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves
-
125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves. J Cell Biol 1986;103:521-34.
-
(1986)
J Cell Biol
, vol.103
, pp. 521-534
-
-
Black, J.D.1
Dolly, J.O.2
-
32
-
-
0022556315
-
125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis
-
125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis. J Cell Biol 1986;103:535-44.
-
(1986)
J Cell Biol
, vol.103
, pp. 535-544
-
-
Black, J.D.1
Dolly, J.O.2
-
33
-
-
70449221816
-
The duration of sustained contractions of the human forearm at different muscle temperatures
-
Clarke RS, Hellon RF, Lind AR. The duration of sustained contractions of the human forearm at different muscle temperatures. J Physiol 1958;143:454-73.
-
(1958)
J Physiol
, vol.143
, pp. 454-473
-
-
Clarke, R.S.1
Hellon, R.F.2
Lind, A.R.3
-
34
-
-
0031449294
-
Therapeutic and research exploitation of botulinum neurotoxins
-
Dolly JO. Therapeutic and research exploitation of botulinum neurotoxins. Eur J Neurol 1997;4 (Suppl 2):S5-10.
-
(1997)
Eur J Neurol
, vol.4
, Issue.SUPPL. 2
-
-
Dolly, J.O.1
-
35
-
-
0021243873
-
Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization
-
Dolly JO, Black JD, Williams RS, Mellin J. Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization. Nature 1984;307:457-60.
-
(1984)
Nature
, vol.307
, pp. 457-460
-
-
Dolly, J.O.1
Black, J.D.2
Williams, R.S.3
Mellin, J.4
-
36
-
-
0018906584
-
Kinetic studies on the interaction between botulinum toxin A and the cholinergic neuromuscular junction
-
Simpson LL. Kinetic studies on the interaction between botulinum toxin A and the cholinergic neuromuscular junction. J Pharmacol Exp Ther 1980;212:16-21.
-
(1980)
J Pharmacol Exp Ther
, vol.212
, pp. 16-21
-
-
Simpson, L.L.1
-
37
-
-
0001718582
-
Influence of nerve-ending activity and of drugs on the rate of paralysis of rat diaphragm preparations by Cl. botulinum A toxin
-
Hughes R, Whaler BC. Influence of nerve-ending activity and of drugs on the rate of paralysis of rat diaphragm preparations by Cl. botulinum A toxin. J Physiol 1962;160:221-3.
-
(1962)
J Physiol
, vol.160
, pp. 221-223
-
-
Hughes, R.1
Whaler, B.C.2
-
38
-
-
0029847230
-
Synaptic vesicle endocytosis mediates the entry of tetanus neurotoxin into hippocampal neurons
-
Matteoli M, Verderio C, Rossetto O, et al. Synaptic vesicle endocytosis mediates the entry of tetanus neurotoxin into hippocampal neurons. Proc Natl Acad Sci U S A 1996;93:13310- 5.
-
(1996)
Proc Natl Acad Sci U S A
, vol.93
, pp. 13310-13315
-
-
Matteoli, M.1
Verderio, C.2
Rossetto, O.3
-
40
-
-
0027366557
-
Identification of the nerve terminal targets of botulinum neurotoxin serotype-A, serotype-D, and serotype-E
-
Schiavo G, Rossetto O, Catsicas S, et al. Identification of the nerve terminal targets of botulinum neurotoxin serotype-A, serotype-D, and serotype-E. J Biol Chem 1993;268:23784 -7.
-
(1993)
J Biol Chem
, vol.268
, pp. 23784-23787
-
-
Schiavo, G.1
Rossetto, O.2
Catsicas, S.3
-
41
-
-
0029026392
-
The synaptic vesicle cycle: A cascade of protein-protein interactions
-
Sudhof TC. The synaptic vesicle cycle: a cascade of protein-protein interactions. Nature 1995;375:645-53.
-
(1995)
Nature
, vol.375
, pp. 645-653
-
-
Sudhof, T.C.1
-
42
-
-
0035890255
-
SNARE complex structure and function
-
Hay JC. SNARE complex structure and function. Exp Cell Res 2001;271:10-21.
-
(2001)
Exp Cell Res
, vol.271
, pp. 10-21
-
-
Hay, J.C.1
-
43
-
-
0033918711
-
Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A infections: A randomized controlled study
-
Gassner H, Serris D. Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A infections: a randomized controlled study. Mayo Clin Proc 2000;75:701-4.
-
(2000)
Mayo Clin Proc
, vol.75
, pp. 701-704
-
-
Gassner, H.1
Serris, D.2
|